☰

Empresas y finanzas

BIO-Europe Spring 2008 Comes to Madrid, Spain


    EBD Group today announced that the second annual BIO-Europe
    Spring(TM) partnering conference will open its doors at the Municipal
    Conference Center, Madrid, Spain, April 7-9, 2008. Like its conference
    counterpart, BIO-Europe, held in the autumn of each year since 1995,
    BIO-Europe Spring is a primary meeting point for international
    biotech, pharma and finance executives to efficiently identify, engage
    and enter into the strategic relationships that drive their businesses
    successfully forward.

    Based on the notable success of BIO-Europe Spring 2007 in Milan,
    Italy (www.bioeuropespring.com), it is anticipated that BIO-Europe
    Spring 2008 will draw in excess of 1,200 industry attendees from more
    than 35 countries, representing over 750 companies, for three days of
    high-level networking. BIO-Europe Spring also features the industry's
    most advanced Web based partnering system that conference delegates
    will use to generate and manage thousands of partnering meetings - the
    previous editions of BIO-Europe and BIO-Europe Spring saw a total of
    7,000 and 4,000 partnering meetings, respectively.

    EBD Group's partnering conferences, such as BIO-Europe Spring,
    BIO-Europe and BioDevice Partnering play a valuable and catalytic role
    in helping firms throughout the biotech value chain forge new
    partnerships. Strategic partnering is contributing an increasingly
    important role towards the success of biotech companies and industry
    at large: From 2003 to 2006, the 50 largest pharmaceutical and biotech
    companies formed more than 1,500 drug discovery alliances, as reported
    by Ernst & Young. Additionally, in 2004, ten of the top selling
    prescription drugs were in-licensed, and from 2000 to 2006 the top 20
    pharmaceutical companies entered into approximately 1,895 alliances
    with biotech companies, according to PharmaVentures' PharmaDeals.

    Commenting on BIO-Europe Spring 2007's value in helping achieve
    strategic partnering goals, Robert Wills, Vice President of Alliance
    Management, Johnson and Johnson, said, "The world is clearly getting
    smaller and it is crucial for companies like ours to reach out to
    cover the globe.... Holding a meeting like this in Southern Europe
    allows us to interact with companies we might otherwise not know
    existed, and to determine if there are matches between our work and
    theirs. One could, conceivably, schedule 30 or 40 meetings over the
    three-day period--which would, otherwise, take a year. By giving big
    pharma and small biotech an international forum in which to interact,
    by all measures, EBD Group's BIO-Europe Spring Partnering Conference
    has been a great success."

    Andy Brookes, Senior Director of Business Development for Biogen
    Idec, International added, "As our company and the industry globalize,
    conferences like this provide important contacts from all over the
    world. We are pleased to take part in a conference with such a vibrant
    atmosphere."

    General registration for BIO-Europe Spring will be available in
    July. For more information about this global partnering event for the
    life science industry, visit EBD Group at booth #1059 in the BIO
    exhibit hall or contact us at the addresses below.

    BIO-Europe Spring is organized by EBD Group, and features a
    partnership with the Biotechnology Industry Organization and local
    support from PromoMadrid and Genoma Espana.

    PromoMadrid, Desarrollo Internacional de Madrid, S.A. is a
    regional government-owned company, incorporated in 2004 with the
    purpose of promoting and developing the Region of Madrid
    internationally from an economic perspective.

    Genoma Espana is the Foundation for the Development of Genomic and
    Proteomic Research. It is backed by the Spanish State through the
    Ministries of Health and Consumer Affairs and Education and Science.

    About EBD Group

    EBD Group is the leading partnering firm for the global
    biotechnology industry. Since 1993, firms in the life sciences have
    leveraged EBD Group's partnering conferences, technology and services
    to identify business opportunities and develop strategic relationships
    that drive their business.

    EBD Group's conferences (run in collaboration with leading
    industry partners and international trade associations such as BIO and
    Eucomed) include BIO-Europe, the world's largest stand-alone life
    science partnering conference; BIO-Europe Spring; the investor
    conference, BioEquity Europe (co-organized with BioCentury
    Publications); and the convergent medical technology partnering
    conference, BioDevice Partnering. EBD's novel, web-based, partnering
    software system is also used at numerous third-party events around the
    world. Outside of the conference format, EBD Group's consultants can
    provide hands-on assistance for firms seeking to in- or out-license
    products and technologies.

    EBD Group has offices in San Diego, Munich and London. For more
    information visit www.ebdgroup.com